Detrimental graft survival of size-mismatched graft for high model for end-stage liver disease recipients in liver transplantation

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 23, Issue 7, 2016, Pages 406-413

  Fukazawa, Kyota ^a   Nishida, Seigo ^b   Pretto, Ernesto A ^b   Vater, Youri ^a   Reyes, Jorge D ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Body surface area; Liver transplant; Model for end stage liver disease; Size mismatch; Survival

Indexed keywords

ARTICLE; BODY SURFACE; COHORT ANALYSIS; CONTROLLED STUDY; END STAGE LIVER DISEASE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MODEL FOR END STAGE LIVER DISEASE SCORE; OUTCOME ASSESSMENT; PATIENT SAFETY; RISK ASSESSMENT; SIZE MISMATCHED GRAFT; SURVIVAL TIME; TRANSPLANTATION; VALIDATION PROCESS;

EID: 84978766600     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1002/jhbp.355     Document Type: Article

References (38)

1. Kiuchi T, Kasahara M, Uryuhara K, Inomata Y, Uemoto S, Asonuma K, et al. Impact of graft size mismatching on graft prognosis in liver transplantation from living donors. Transplantation. 1999;67:321–7.
2. Kiuchi T, Onishi Y, Nakamura T. Small-for-size graft: not defined solely by being small for size. Liver Transpl. 2010;16:815–17.
3. Urata K, Kawasaki S, Matsunami H, Hashikura Y, Ikegami T, Ishizone S, et al. Calculation of child and adult standard liver volume for liver transplantation. Hepatology. 1995;21:1317–21.
4. Dahm F, Georgiev P, Clavien PA. Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications. Am J Transplant. 2005;5:2605–10.
5. Ben-Haim M, Emre S, Fishbein TM, Sheiner PA, Bodian CA, Kim-Schluger L, et al. Critical graft size in adult-to-adult living donor liver transplantation: impact of the recipient's disease. Liver Transpl. 2001;7:948–53.
6. Olthoff KM, Merion RM, Ghobrial RM, Abecassis MM, Fair JH, Fisher RA, et al. Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg. 2005;242:314–23.
7. Katsuragawa H, Yamamoto M, Katagiri S, Yoshitoshi K, Ariizumi S, Kotera Y, et al. Graft size and donor age are independent factors for graft loss in adult-to-adult living-donor liver transplantation using the left liver. J Hepatobiliary Pancreat Surg. 2009;16:178–83.
8. Heaton N. Small-for-size liver syndrome after auxiliary and split liver transplantation: donor selection. Liver Transpl. 2003;9:S26–8.
9. Organ Procurement and Transplantation Network. U.S. liver transplants performed: January 1, 1988 - August 31, 2014. [Cited 6 May 2014]. Available from: http://optn.transplant.hrsa.gov/
10. Fukazawa K, Nishida S, Volsky A, Tzakis AG, Pretto EA Jr. Body surface area index predicts outcome in orthotopic liver transplantation. J Hepatobiliary Pancreat Sci. 2011;18:216–25.
11. Fukazawa K, Yamada Y, Nishida S, Hibi T, Arheart KL, Pretto EA Jr. Determination of the safe range of graft size mismatch using body surface area index in deceased liver transplantation. Transpl Int. 2013;26:724–33.
12. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464–70.
13. Ikegami T, Shirabe K, Yoshiya S, Yoshizumi T, Yamashita Y, Harimoto N, et al. A high MELD score, combined with the presence of hepatitis C, is associated with a poor prognosis in living donor liver transplantation. Surg Today. 2014;44:233–40.
14. Marubashi S, Nagano H, Eguchi H, Wada H, Asaoka T, Tomimaru Y, et al. Minimum graft size calculated from preoperative recipient status in living donor liver transplantation. Liver Transpl. 2016;22:599–606.
15. Kamath PS, Kim WR. Advanced Liver Disease Study G. The model for end-stage liver disease (MELD). Hepatology. 2007;45:797–805.
16. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology. 1988;8:1151–7.
17. Bellot P, Frances R, Such J. Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications. Liver Int. 2013;33:31–9.
18. Wiest R, Das S, Cadelina G, Garcia-Tsao G, Milstien S, Groszmann RJ. Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility. J Clin Invest. 1999;104:1223–33.
19. Frances R, Zapater P, Gonzalez-Navajas JM, Munoz C, Cano R, Moreu R, et al. Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis. Hepatology. 2008;47:978–85.
20. Martin PY, Gines P, Schrier RW. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N Engl J Med. 1998;339:533–41.
21. Glanemann M, Eipel C, Nussler AK, Vollmar B, Neuhaus P. Hyperperfusion syndrome in small-for-size livers. Eur Surg Res. 2005;37:335–41.
22. Demetris AJ, Kelly DM, Eghtesad B, Fontes P, Wallis Marsh J, Tom K, et al. Pathophysiologic observations and histopathologic recognition of the portal hyperperfusion or small-for-size syndrome. Am J Surg Pathol. 2006;30:986–93.
23. Smyrniotis V, Kostopanagiotou G, Kondi A, Gamaletsos E, Theodoraki K, Kehagias D, et al. Hemodynamic interaction between portal vein and hepatic artery flow in small-for-size split liver transplantation. Transpl Int. 2002;15:355–60.
24. Ogura Y, Hori T, El Moghazy WM, Yoshizawa A, Oike F, Mori A, et al. Portal pressure < 15 mm Hg is a key for successful adult living donor liver transplantation utilizing smaller grafts than before. Liver Transpl. 2010;16:718–28.
25. Asakura T, Ohkohchi N, Orii T, Koyamada N, Tsukamoto S, Sato M, et al. Portal vein pressure is the key for successful liver transplantation of an extremely small graft in the pig model. Transpl Int. 2003;16:376–82.
26. Ito T, Kiuchi T, Yamamoto H, Oike F, Ogura Y, Fujimoto Y, et al. Changes in portal venous pressure in the early phase after living donor liver transplantation: pathogenesis and clinical implications. Transplantation. 2003;75:1313–7.
27. Li J, Liang L, Ma T, Yu X, Chen W, Xu G, et al. Sinusoidal microcirculatory changes after small-for-size liver transplantation in rats. Transpl Int. 2010;23:924–33.
28. Uemura T, Wada S, Kaido T, Mori A, Ogura Y, Yagi S, et al. How far can we lower graft-to-recipient weight ratio for living donor liver transplantation under modulation of portal venous pressure? Surgery. 2016;159:1623–30.
29. Sato Y, Yamamoto S, Oya H, Nakatsuka H, Tsukahara A, Kobayashi T, et al. Splenectomy for reduction of excessive portal hypertension after adult living-related donor liver transplantation. Hepatogastroenterology. 2002;49:1652–5.
30. Troisi R, Cammu G, Militerno G, De Baerdemaeker L, Decruyenaere J, Hoste E, et al. Modulation of portal graft inflow: a necessity in adult living-donor liver transplantation? Ann Surg. 2003;237:429–36.
31. Yagi S, Iida T, Hori T, Taniguchi K, Yamamoto C, Yamagiwa K, et al. Optimal portal venous circulation for liver graft function after living-donor liver transplantation. Transplantation. 2006;81:373–8.
32. Yamada T, Tanaka K, Uryuhara K, Ito K, Takada Y, Uemoto S. Selective hemi-portocaval shunt based on portal vein pressure for small-for-size graft in adult living donor liver transplantation. Am J Transplant. 2008;8:847–53.
33. Boillot O, Delafosse B, Mechet I, Boucaud C, Pouyet M. Small-for-size partial liver graft in an adult recipient; a new transplant technique. Lancet. 2002;359:406–7.
34. Oura T, Taniguchi M, Shimamura T, Suzuki T, Yamashita K, Uno M, et al. Does the permanent portacaval shunt for a small-for-size graft in a living donor liver transplantation do more harm than good? Am J Transplant. 2008;8:250–2.
35. Shimada M, Fujii M, Morine Y, Imura S, Ikemoto T, Ishibashi H. Living-donor liver transplantation: present status and future perspective. J Med Invest. 2005;52:22–32.
36. Onaca NN, Levy MF, Netto GJ, Thomas MJ, Sanchez EQ, Chinnakotla S, et al. Pretransplant MELD score as a predictor of outcome after liver transplantation for chronic hepatitis C. Am J Transplant. 2003;3:626–30.
37. Halldorson JB, Bakthavatsalam R, Fix O, Reyes JD, Perkins JD. D-MELD, a simple predictor of post liver transplant mortality for optimization of donor/recipient matching. Am J Transplant. 2009;9:318–26.
38. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31:864–71.